ROCKVILLE, Md., May 10, 2022 (GLOBE NEWSWIRE) -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of ...
Synthetic Biologics, Inc. SYN announced positive top-line results from the first phase IIa study on SYN-004 for protecting gut microbiome from the unintended effects of certain commonly used ...
This is a preview. Log in through your library . Abstract The package is especially useful for exploring data structures and for summarizing information in large data sets in a convenient way. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback